Health
Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells – News-Medical.Net
A new study by researchers at NYU Langone Medical Center and Weill Cornell Medical College and published on the preprint server bioRxiv* in September 2020 reports the potential of an angiotensin-converting enzyme 2 (ACE2)-antibody Fc complex in a new format t…
As the COVID-19 pandemic continues to spread in many parts of the world, there is an urgent need for a preventative vaccine and improved therapeutics. A new study by researchers at NYU Langone Medical Center and Weill Cornell Medical College and published on the preprint server bioRxiv* in September 2020 reports the potential of an angiotensin-converting enzyme 2 (ACE2)-antibody Fc complex in a new format that seems to offer more significant inhibition of SARS-CoV-2.
ACE2 has been one of the pr…
-
Noosa News23 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
General17 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business21 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
Noosa News21 hours agoPalestine protesters forced into last-minute reroute